Search
Tefinostat
go.drugbank.com/drugs/DB15321InvestigationalTefinostat is under investigation in clinical trial NCT02759601 (Dose Escalation Trial of Tefinostat for Cancer Associated Inflamation in Hepatocellular Carcinoma (HCC)).
Temelimab
go.drugbank.com/drugs/DB15634InvestigationalTemelimab is under investigation in clinical trial NCT02782858 (Clinical Trial Assessing the HERV-W Env Antagonist Gnbac1 for Efficacy in MS).
TGAAC09
go.drugbank.com/drugs/DB06363InvestigationalIt was under investigation in clinical trials NCT00482027 and NCT00888446 for the treatment of HIV Infection.
Calcimycin
go.drugbank.com/drugs/DB19408InvestigationalPrimarily used as a biochemical tool for studying divalent cations in biological systems, Calcimycin also exhibits antibiotic activity against gram-positive bacteria and fungi.
Categories: Compounds used in a research, industrial, or household settingAcetoxolone
go.drugbank.com/drugs/DB13640ExperimentalCategories: Drugs for Acid Related Disorders, Drugs for Peptic Ulcer and Gastro-Oesophageal Reflux Disease (Gord)Pegvisomant
go.drugbank.com/drugs/DB00082ApprovedInvestigationalUnlike dopamine or somatostatin analogs (which inhibit growth hormone secretion), this drug actually blocks the hepatic (GH-mediated) production of insulin like growth factor (IGF-1), which is the main
Rauwolfia serpentina root
go.drugbank.com/drugs/DB09363InvestigationalFor this reason, various studies into biotechnological applications of this plant have been performed. … This product was approved prior to Jan 1, 1982, but since, has been discontinued due to its propensity for leading to depression [L1616, L1630].
SRP 299
go.drugbank.com/drugs/DB05440ExperimentalSRP 299 is a preparation of killed Mycobacterium vaccae that has been tested in uses related to inhibiting periodontal disease, in treating asthma and in treating eczema, itching and inflammation. Mycobacterium vaccae is a non-pathogenic...
Atipamezole
go.drugbank.com/drugs/DB11481InvestigationalVet approvedIt has also been undergone research as a potential anti-Parkinsonian drug for humans.
Amilomotide
go.drugbank.com/drugs/DB05150InvestigationalCAD106 is an immunotherapeutic product in development for the treatment of Alzheimer's disease.